Ayman Abouzayed
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
-
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
Papers in
-
- Radiopharmaceutical Chemistry and Applications 21
- Monoclonal and Polyclonal Antibodies Research 8
- Oncology 22
- Peptidase Inhibition and Analysis 15
- HER2/EGFR in Cancer Research 6
- Co-authors
- Anna Orlova (28 shared papers)Vladimir Tolmachev (24 shared papers)Sara S. Rinne (13 shared papers)Ulrika Rosenström (11 shared papers)Bogdan Mitran (6 shared papers)Mats Larhed (3 shared papers)Anzhelika Vorobyeva (8 shared papers)John Löfblom (6 shared papers)
In The Last Decade
Ayman Abouzayed
28 papers receiving 364 citations
Peers
Comparison fields: 5 of 38
- Radiology, Nuclear Medicine and Imaging 246
- Oncology 157
- Pulmonary and Respiratory Medicine 120
- Cellular and Molecular Neuroscience 45
- Epidemiology 47
Countries citing papers authored by Ayman Abouzayed
This map shows the geographic impact of Ayman Abouzayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Abouzayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Abouzayed more than expected).
Fields of papers citing papers by Ayman Abouzayed
This network shows the impact of papers produced by Ayman Abouzayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Abouzayed. The network helps show where Ayman Abouzayed may publish in the future.
Co-authors
The 25 scholars most cited alongside Ayman Abouzayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 43 | |
| 2 | 2023 | 28 | |
| 3 | 2019 | 28 | |
| 4 | 2019 | 27 | |
| 5 | 2020 | 27 | |
| 6 | 2019 | 25 | |
| 7 | 2022 | 24 | |
| 8 | 2020 | 19 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 11 | |
| 13 | 2023 | 11 | |
| 14 | 2022 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2020 | 8 | |
| 17 | 2024 | 8 | |
| 18 | 2024 | 6 | |
| 19 | 2019 | 6 | |
| 20 | 2023 | 5 |
About Ayman Abouzayed
Ayman Abouzayed is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Cellular and Molecular Neuroscience and Epidemiology, having authored 31 papers that have together received 364 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (21 papers), Peptidase Inhibition and Analysis (15 papers), Prostate Cancer Treatment and Research (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Neuropeptides and Animal Physiology (6 papers), HER2/EGFR in Cancer Research (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (246 citations), Oncology (157 citations), Pulmonary and Respiratory Medicine (120 citations), Cellular and Molecular Neuroscience (45 citations) and Epidemiology (47 citations). Ayman Abouzayed has collaborated with scholars based in Sweden, Russia and Greece. Frequent co-authors include Anna Orlova, Vladimir Tolmachev, Sara S. Rinne, Ulrika Rosenström, Bogdan Mitran, Mats Larhed, Anzhelika Vorobyeva, John Löfblom, Zohreh Varasteh and Stefan Ståhl. Their work appears in journals such as Pharmaceutics, EJNMMI Radiopharmacy and Chemistry, Cancers, Scientific Reports and ACS Omega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.